Prestige Consumer Healthcare Inc. earnings per share and revenue
On 06 de nov. de 2025, PBH reported earnings of 1.07 USD per share (EPS) for Q2 26, beating the estimate of 0.98 USD, resulting in a 9.18% surprise. Revenue reached 274.11 milhão, compared to an expected 259.70 milhão, with a 5.55% difference. The market reacted with a +2.56% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analistas forecast an EPS of 1.14 USD, with revenue projected to reach 283.95 milhão USD, implying an aumentar of 6.54% EPS, and aumentar of 3.59% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Neogen Corp
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
$0.05
Real
$0.10
Surpresa
+78.25%
Tilray Brands, Inc. Common Stock
Report Date
08 de jan. de 2026 Para Q2 26
Estimativa
-$0.20
Real
-$0.41
Surpresa
-100.98%
FAQ
What were Prestige Consumer Healthcare Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Prestige Consumer Healthcare Inc. reported EPS of $1.07, beating estimates by 9.18%, and revenue of $274.11M, 5.55% above expectations.
How did the market react to Prestige Consumer Healthcare Inc.'s Q2 2026 earnings?
The stock price moved up 2.56%, changed from $59.83 before the earnings release to $61.36 the day after.
When is Prestige Consumer Healthcare Inc. expected to report next?
The next earning report is scheduled for 05 de fev. de 2026.
What are the forecasts for Prestige Consumer Healthcare Inc.'s next earnings report?
Based on 8
analistas, Prestige Consumer Healthcare Inc. is expected to report EPS of $1.14 and revenue of $283.95M for Q3 2026.